Bitcoin surges above $39K with the latest election results where the Democrats seem to be winning and this helped boost the sentiment
Moderna’s CEO Claims Covid-19 mRNA vaccine is likely to offer protection of up to a couple of years
Treating critically ill Covid-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive...
China Locks Down City As 200 Cases Confirmed; Brazilian Study Finds SinoVac Jab 78% Effective: Live Update
T-Mobile released preliminary fourth quarter and full-year 2020 results yesterday that highlighted postpaid net additions of 5.5 million customers for the year.
Shares of Nvidia Corp. fell almost 6% yesterday after the Competition and Markets Authority (CMA) announced that it would be investigating Nvidia’s $40 billion deal to...
Rising COVID-19 cases continue to hurt Carnival Corporation’s cruise lines, including Holland America Line and Princess Cruises, with both announcing additional cancellations due to pandemic-led uncertainties....
Alibaba is planning to raise as much as $8 billion by selling US dollar-denominated bonds as early as next week
After delaying its decision earlier this week, the EMA announced it has formally recommended authorizing Moderna’s Covid-19 vaccine
It may be two months before Moderna and the NIH can conclude whether they can halve their vaccine dose and provide the same level of protection
Scientists at the NIH and Moderna may take about two months to determine whether doses of the company’s Covid-19 vaccine can be halved
Dentsply Sirona has bought teeth aligner company Byte in an all-cash deal for $1.04 billion, in a move to expand its business growing market for online...
Tinkering with the dosing schedule of COVID-19 vaccines runs a “significant risk” to public health, the FDA has warned
The full 2-dose regimen efficacy of AstraZeneca Covid-19 vaccine was 62%, compared with 95% efficacy for Pfizer/BioNTech
Moderna Inc. plans to produce at least 600 million doses of the company's Covid-19 vaccine in 2021, up by 100 million doses from the previous forecast
So far, the only COVID-19 vaccines authorized for use need to be kept frozen or refrigerated. But there are many places in the world that can't...
What's Behind Today's Sudden Selloff: The Answer Lies In Georgia
Commentary on America’s overvalued stock market can be found pretty much everywhere these days.
The COVID-19 vaccine developed by AstraZeneca and Oxford University has been approved by the Indian drug regulator for emergency use,
Centene Corp. has entered into a merger agreement to buy Magellan Health in an all-cash deal valued at $2.2 billion, in a move to strengthen its...
Talks have stalled again and again but a mini deal could be imminent.
Shares of Tiziana Life Sciences jumped 16% in Monday's pre-market trading after the biotech company announced the completion of the Brazil clinical trial of its nasally...
Experts at India’s drugs regulator approved two coronavirus vaccines for emergency use: one developed by AstraZeneca/Oxford University, and the other backed by a state-run SIIPL institute.
U.S. Senator Mitt Romney urged the U.S. government to immediately enlist veterinarians, combat medics and others in an all-out national campaign to administer coronavirus vaccinations
Delta Air Lines continues to expect to achieve positive cash flow by the spring, the carrier’s CEO Ed Bastian stated in a New Year note to...
Pfizer and its German partner BioNTech are planning to offer free vaccination to those volunteers who received a placebo that remain in the Phase 4 study.
Investing in a state of fear is to buy likely winners and hedge away the fear.
Some 20%-50% California's health workers are refusing to take the new COVID-19 vaccines preferring to rely on PPE top protect their health
Welcome back to This Week in Apps, the weekly TechCrunch series that recaps the latest in mobile OS news, mobile applications and the overall app economy.
The prospects for 2021 look bright as major forces driving adoption in 2020 will remain powerful.